BIONYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO.B

BIO-RAD LABORATORIES, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$352.82−0.88 (-0.25%)

Close on Oct 19, 2026

Community

Notes and questions about Bio-Rad Laboratories from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Bio-Rad Laboratories's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Mar 8, 2002
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BIO.

Revenue growth1.4% · median 4.1%

Gross margin51.9% · median 46.4%

Operating margin2.1% · median 7.1%

Net margin8.6% · median 3.6%

Advertisement
300 × 250